कुल 50 हाल के अंदरूनी लेनदेन दर्ज हैं Tarsus Pharmaceuticals, Inc. (TARS), जिसमें शामिल हैं 9 खरीद और 38 बिक्री. कुल अंदरूनी खरीद मूल्य RSU पुरस्कार और कुल अंदरूनी बिक्री मूल्य $8.71M.
हाल की गतिविधि वाले उल्लेखनीय अंदरूनी लोगों में शामिल हैं Neervannan Seshadri, Farrow Jeffrey S, Mottiwala Aziz. अंदरूनी लेनदेन से पता चल सकता है कि कंपनी का नेतृत्व स्टॉक के मूल्यांकन और भविष्य की संभावनाओं को कैसे देखता है.
इनसाइडर ट्रेडिंग — TARS
| तिथि |
नाम |
भूमिका |
लेनदेन प्रकार |
शेयर |
औसत मूल्य |
मूल्य |
स्वामित्व वाले शेयर |
| 2026-03-20 |
Neervannan Seshadri |
Chief Operating Officer |
सूचित बिक्री |
2,989 |
$66.75 |
$199.52K |
82,791 |
| 2026-03-19 |
Farrow Jeffrey S |
See Remarks |
सूचित बिक्री |
2,186 |
$67.00 |
$146.46K |
43,316 |
| 2026-03-19 |
Mottiwala Aziz |
Chief Commercial Officer |
सूचित बिक्री |
4,440 |
$67.00 |
$297.48K |
61,480 |
| 2026-03-19 |
Neervannan Seshadri |
Chief Operating Officer |
सूचित बिक्री |
4,589 |
$67.00 |
$307.46K |
85,780 |
| 2026-03-19 |
Azamian Bobak R. |
President/ceo and Board Chair |
सूचित बिक्री |
11,964 |
$67.00 |
$801.59K |
33,421 |
| 2026-03-19 |
Whitfield Dianne C. |
Chief Human Resources Officer |
सूचित बिक्री |
4,174 |
$67.00 |
$279.66K |
35,028 |
| 2026-03-19 |
Wahl Bryan |
General Counsel |
सूचित बिक्री |
4,231 |
$67.00 |
$283.48K |
63,959 |
| 2026-03-19 |
Lin Elizabeth Yeu |
Chief Medical Officer |
सूचित बिक्री |
390 |
$67.00 |
$26.13K |
23,308 |
| 2026-03-18 |
Farrow Jeffrey S |
See Remarks |
सूचित बिक्री |
2,133 |
$68.71 |
$146.56K |
45,502 |
| 2026-03-18 |
Mottiwala Aziz |
Chief Commercial Officer |
सूचित बिक्री |
4,330 |
$68.71 |
$297.51K |
65,920 |
| 2026-03-18 |
Neervannan Seshadri |
Chief Operating Officer |
सूचित बिक्री |
3,610 |
$68.71 |
$248.04K |
90,369 |
| 2026-03-18 |
Azamian Bobak R. |
President/ceo and Board Chair |
सूचित बिक्री |
11,667 |
$68.71 |
$801.64K |
45,385 |
| 2026-03-18 |
Whitfield Dianne C. |
Chief Human Resources Officer |
सूचित बिक्री |
4,071 |
$68.71 |
$279.72K |
39,202 |
| 2026-03-18 |
Wahl Bryan |
General Counsel |
सूचित बिक्री |
4,125 |
$68.71 |
$283.43K |
68,190 |
| 2026-03-18 |
Lin Elizabeth Yeu |
Chief Medical Officer |
सूचित बिक्री |
379 |
$68.71 |
$26.04K |
23,698 |
| 2026-03-17 |
Farrow Jeffrey S |
See Remarks |
सूचित बिक्री |
2,111 |
$69.42 |
$146.55K |
47,635 |
| 2026-03-17 |
Mottiwala Aziz |
Chief Commercial Officer |
सूचित बिक्री |
4,286 |
$69.42 |
$297.53K |
70,250 |
| 2026-03-17 |
Neervannan Seshadri |
Chief Operating Officer |
सूचित बिक्री |
3,125 |
$69.42 |
$216.94K |
93,979 |
| 2026-03-17 |
Azamian Bobak R. |
President/ceo and Board Chair |
सूचित बिक्री |
10,972 |
$69.42 |
$761.68K |
57,052 |
| 2026-03-17 |
Whitfield Dianne C. |
Chief Human Resources Officer |
सूचित बिक्री |
4,029 |
$69.42 |
$279.69K |
43,273 |
| 2026-03-17 |
Wahl Bryan |
General Counsel |
सूचित बिक्री |
4,084 |
$69.42 |
$283.51K |
72,315 |
| 2026-03-17 |
Lin Elizabeth Yeu |
Chief Medical Officer |
सूचित बिक्री |
375 |
$69.42 |
$26.03K |
24,077 |
| 2026-03-16 |
Link William J Phd |
Director |
सूचित बिक्री |
493 |
$69.75 |
$34.39K |
116,332 |
| 2026-03-15 |
Farrow Jeffrey S |
See Remarks |
विकल्प प्रयोग (बिक्री) |
5,022 |
- |
- |
15,067 |
| 2026-03-15 |
Mottiwala Aziz |
Chief Commercial Officer |
विकल्प प्रयोग (बिक्री) |
4,790 |
- |
- |
- |
| 2026-03-15 |
Neervannan Seshadri |
Chief Operating Officer |
विकल्प प्रयोग (बिक्री) |
5,097 |
- |
- |
- |
| 2026-03-15 |
Azamian Bobak R. |
President/ceo and Board Chair |
विकल्प प्रयोग (बिक्री) |
11,300 |
- |
- |
- |
| 2026-03-15 |
Whitfield Dianne C. |
Chief Human Resources Officer |
विकल्प प्रयोग (बिक्री) |
4,463 |
- |
- |
- |
| 2026-03-15 |
Wahl Bryan |
General Counsel |
विकल्प प्रयोग (बिक्री) |
4,790 |
- |
- |
- |
| 2026-03-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
विकल्प प्रयोग (बिक्री) |
2,511 |
- |
- |
7,534 |
| 2026-03-05 |
Farrow Jeffrey S |
See Remarks |
RSU पुरस्कार |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Mottiwala Aziz |
Chief Commercial Officer |
RSU पुरस्कार |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Neervannan Seshadri |
Chief Operating Officer |
RSU पुरस्कार |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Azamian Bobak R. |
President/ceo and Board Chair |
RSU पुरस्कार |
60,776 |
- |
- |
60,776 |
| 2026-03-05 |
Whitfield Dianne C. |
Chief Human Resources Officer |
RSU पुरस्कार |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Wahl Bryan |
General Counsel |
RSU पुरस्कार |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Lin Elizabeth Yeu |
Chief Medical Officer |
RSU पुरस्कार |
17,161 |
- |
- |
17,161 |
| 2026-03-04 |
Neervannan Seshadri |
Chief Operating Officer |
सूचित बिक्री |
8,366 |
$76.67 |
$641.42K |
70,817 |
| 2026-02-18 |
Pyott David E I |
Director |
अज्ञात |
7,000 |
$12.97 |
$90.79K |
- |
| 2026-02-18 |
Pyott David E I |
Director |
RSU पुरस्कार |
3,729 |
- |
- |
3,729 |
| 2026-01-02 |
Whitfield Dianne C. |
Chief Human Resources Officer |
सूचित बिक्री |
893 |
$82.93 |
$74.06K |
23,393 |
| 2025-12-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
सूचित बिक्री |
557 |
$83.54 |
$46.53K |
857,991 |
| 2025-12-16 |
Lin Elizabeth Yeu |
Chief Medical Officer |
सूचित बिक्री |
2,078 |
$79.50 |
$165.2K |
21,941 |
| 2025-12-16 |
Neervannan Seshadri |
Chief Operating Officer |
उपहार (प्राप्त) |
475 |
- |
- |
475 |
| 2025-12-16 |
Whitfield Dianne C. |
Chief Human Resources Officer |
सूचित बिक्री |
7,397 |
$80.10 |
$592.5K |
38,958 |
| 2025-12-15 |
Goodrich Katherine |
Director |
विकल्प प्रयोग |
2,233 |
- |
- |
2,233 |
| 2025-12-15 |
Link William J Phd |
Director |
सूचित बिक्री |
4,766 |
$81.50 |
$388.43K |
- |
| 2025-12-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
विकल्प प्रयोग (बिक्री) |
6,819 |
- |
- |
20,459 |
| 2025-12-04 |
Azamian Bobak R. |
President/ceo and Board Chair |
उपहार (दिया) |
51,885 |
- |
- |
1,750 |
| 2025-09-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
सूचित बिक्री |
6,000 |
$55.37 |
$332.22K |
812,106 |
■ जानकारीपूर्ण — खुले बाजार में खरीद/बिक्री (सर्वाधिक महत्वपूर्ण)
■ गैर-जानकारी खरीद — पुरस्कार, विकल्प अभ्यास, रूपांतरण
■ गैर-जानकारी बिक्री — कर रोक, पुरस्कार बिक्री
■ तटस्थ — उपहार, ट्रस्ट, समाप्ति
